Bioray Biotech Co (7561.TWO) Stock Price

Bioray Biotech Co Price

CLOSED
17.50
​
Market closed

Revenue has compounded at 7.6% per year over the past 8 years to 222.73 M TWD. Earnings per share have grown at 26.9% per year over the last 8 years. Bioray Biotech Co's net margin stands at 14.5%, up from -4.9% several years earlier. Bioray Biotech Co currently offers a dividend yield of about 1.14%.

Bioray Biotech Co stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Bioray Biotech Co business model & stock analysis

Bioray Biotech Co Ltd is a company based in Tainan, Taiwan, operating within the Health Care sector, specifically in the Biotechnology industry. The company went public on July 6, 2020, with its ticker listed as 7561.TWO and ISIN TW0007561B13. Bioray Biotech focuses on the development of biological health products, functional medical testing, and cell storage and preparation services. The company's product portfolio includes personalized probiotics, anti-allergic and intestinal probiotics, diabetes probiotics, and female urinary tract health products. In the functional medical testing segment, the company offers services such as personalized bacteria testing, personalized fungi testing, intestinal normal bacteria analysis, quantitative detection of magnesium in red blood cells, polymorphism analysis of metabolic-related genes, and lymphocyte grouping. For cell storage and preparation, Bioray Biotech provides stem cell storage, immune cell storage, and cytokine-induced killer (CIK) immune cell preparations. The company's website is https://bio-ray.com.tw/, where further information about its services and products can be found. Bioray Biotech is engaged in the development and provision of specialized health-related services and products, primarily targeting personalized health solutions through biotechnology.

Frequently asked questions about Bioray Biotech Co

Converted at the current exchange rate, the Bioray Biotech Co share trades at 0.48 EUR (17.50 TWD).

The revenue cannot currently be calculated for Bioray Biotech Co.

The profit cannot currently be calculated for Bioray Biotech Co.

The P/E ratio cannot be calculated for Bioray Biotech Co at the moment.

The P/S cannot be calculated for Bioray Biotech Co currently.

The Eulerpool Quality Score for Bioray Biotech Co is 3/10.

The ISIN of Bioray Biotech Co is TW0007561B13. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Bioray Biotech Co is 7561.TWO. The ticker symbol is used to trade Bioray Biotech Co shares on the stock exchange.

Fair ValueTerminal
16.80 TWD
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Biotechnology
Number of shares
Employees
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Country
Taiwan
Currency
TWD
Initial public offering
Jul 6, 2020
ISIN
TW0007561B13
Cusip
Y0906W107
Market capitalization
526.58 M TWDSmall Cap
52-Week Range
PEG
—
P/E ratio
P/Ee
—
P/S
P/Se
—
EV/EBIT
8.51
P/B Ratio
1.16
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
7.12 %
Dividend
Dividend yield
0.00 %
Payout Ratio
0.00 %
Dividend growth Ø5Y
—
Dividend payments per year
1
Dividend paid since
0 years
Dividend not reduced since
0 years
Dividend increased since
0 years
Dividend withholding tax
21.00 %
Last updated Oct 16, 2026, 1:15 AM

Bioray Biotech Co Peer Group

Bioray Biotech Co FIGI

7561:TT (Taipei Stock Exchange) · BBG00M647TP8